Three new genetic variants that increase testicular cancer risk

Jun 15, 2010
Three new genetic variants that increase testicular cancer risk
Testicular cancer. Credit: Katie Mayfield, Wellcome Images.

(PhysOrg.com) -- A study led by the Institute of Cancer Research (ICR) has identified three new genetic risk factors for testicular cancer, taking the number of genomic regions known to be associated with testicular cancer risk to six.

The findings, published online today in 'Nature Genetics', come during Everyman Male Cancer Awareness Month, which aims to increase awareness and funding for vital research into testicular and prostate cancers. The study was funded by the Everyman Campaign, Cancer Research UK and the Wellcome Trust.

Researchers from the ICR, the Wellcome Trust Sanger Institute and the Cancer Research UK Genetic Epidemiology Units in Cambridge and at the University of Leeds scanned the genomes of almost 1000 men with and almost 5000 apparently unaffected individuals. They found that genetic variants in three regions were significantly more common in the men with testicular cancer and confirmed the results in a further 670 men with cancer and 3500 controls.

Men who have any of the variants on chromosomes 5, 12 and 9 have an increased risk of testicular cancer. Within each region, the researchers pinpointed an interesting gene most likely to be involved in causing testicular cancer: the genes are known as TERT, ATF7IP and DMRT1 respectively.

TERT and ATF7IP are important in maintaining the correct length of the ends of , which are called telomeres. Shortened are known to occur in many cancers and genetic variants in TERT have already been linked to other cancers, including lung, bladder, cervical, pancreatic, skin and prostate cancers. The third gene identified in this new study, DMRT1, is pivotal in sex determination and has been implicated in the development of testicular cancer in mice.

Senior author Professor Nazneen Rahman, from the ICR, says: "The genes located in these regions give us clues to the mechanisms by which testicular cancer develops. In time this may allow us to develop new treatment options."

Lead author Dr Clare Turnbull, also from the ICR, says: "This study represents further, important progress towards identifying men who are at increased genetic risk of testicular cancer. Finding those men at highest risk may allow early detection or prevention of the disease."

Explore further: Leukemia drug shows promise for skin, breast and other cancers

More information: Turnbull C et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 2010 [Epub ahead of print].

add to favorites email to friend print save as pdf

Related Stories

Male infertility associated with testicular cancer

Feb 23, 2009

Men who are infertile appear to have an increased risk of developing testicular cancer, according to a report in the February 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Recommended for you

Biomarker in aggressive breast cancer identified

8 hours ago

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, ...

MRI better detects recurrent breast cancer

9 hours ago

(HealthDay)—Single-screening breast magnetic resonance imaging (MRI) detects 18.1 additional cancers after negative findings with mammography and ultrasonography (US) per 1,000 women with a history of breast ...

Natural (born) killer cells battle pediatric leukemia

21 hours ago

Researchers at Children's Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells that ...

User comments : 0